Literature DB >> 25587925

Luteolin attenuate the D-galactose-induced renal damage by attenuation of oxidative stress and inflammation.

Yuqing Xu1, Jingzheng Zhang, Jing Liu, Sai Li, Cheng Li, Wen Wang, Rong Ma, Yi Liu.   

Abstract

Luteolin is reported to have antioxidant and anti-inflammatory properties. In this study, we investigated the protective effect of luteolin against the renal damage induced by D-galactose (D-gal). The levels of creatinine (Cr) and urea nitrogen (BUN) were evaluated in plasma, kidney sections were stained with haematoxylin-eosin, followed by assessment of the antioxidant and anti-inflammatory activity. Furthermore, we also investigated the expression of the p38 mitogen-activated protein kinase (p38 MAPK) and its phosphorylated activation. The results of luteolin treatment showed that the renal damages were attenuated. Luteolin could significantly ameliorate D-gal-induced oxidative damage and suppress the inflammatory response. Moreover, the result also shows that luteolin could significantly inhibit the p38 MAPK phosphorylation in the kidneys from the model of D-gal-treated mice. Therefore, our research suggests that luteolin might be involved in the attenuated oxidative stress and inflammatory responses, hence the protective effects against D-gal-induced renal damage.

Entities:  

Keywords:  d-galactose; inflammation; kidney; luteolin; oxidative stress

Mesh:

Substances:

Year:  2015        PMID: 25587925     DOI: 10.1080/14786419.2014.981181

Source DB:  PubMed          Journal:  Nat Prod Res        ISSN: 1478-6419            Impact factor:   2.861


  8 in total

1.  Evidence of oxidative stress in brain and liver of young rats submitted to experimental galactosemia.

Authors:  Márcia B Castro; Bruna K Ferreira; José Henrique Cararo; Adália E Chipindo; Marina L Magenis; Monique Michels; Lucinéia G Danielski; Marcos R de Oliveira; Gustavo C Ferreira; Emilio L Streck; Fabricia Petronilho; Patrícia F Schuck
Journal:  Metab Brain Dis       Date:  2016-07-07       Impact factor: 3.584

2.  Luteolin, a novel p90 ribosomal S6 kinase inhibitor, suppresses proliferation and migration in leukemia cells.

Authors:  Lan Deng; Ling Jiang; Xianghua Lin; Kuo-Fu Tseng; Zhigang Lu; Xiuju Wang
Journal:  Oncol Lett       Date:  2017-01-11       Impact factor: 2.967

Review 3.  Bioactive Compounds and Their Neuroprotective Effects in Diabetic Complications.

Authors:  Yoon Sin Oh
Journal:  Nutrients       Date:  2016-07-30       Impact factor: 5.717

4.  Protective Effects of Luteolin on Lipopolysaccharide-Induced Acute Renal Injury in Mice.

Authors:  Shao-Bin Xin; Hao Yan; Jing Ma; Qiang Sun; Li Shen
Journal:  Med Sci Monit       Date:  2016-12-28

5.  Luteolin Treatment Protects against Renal Ischemia-Reperfusion Injury in Rats.

Authors:  Xin Hong; Xiaojing Zhao; Gang Wang; Zhengliang Zhang; Honghong Pei; Zhong Liu
Journal:  Mediators Inflamm       Date:  2017-11-21       Impact factor: 4.711

6.  Luteolin attenuates angiotensin II‑induced renal damage in apolipoprotein E‑deficient mice.

Authors:  Ying-Shu Liu; Qin Yang; Shen Li; Lan Luo; Hong-Yang Liu; Xin-Yu Li; Zheng-Nan Gao
Journal:  Mol Med Rep       Date:  2020-12-23       Impact factor: 2.952

7.  Luteolin Prevents H2O2-Induced Apoptosis in H9C2 Cells through Modulating Akt-P53/Mdm2 Signaling Pathway.

Authors:  Hong Chang; Chun Li; Kuiyuan Huo; Qiyan Wang; Linghui Lu; Qian Zhang; Yong Wang; Wei Wang
Journal:  Biomed Res Int       Date:  2016-07-25       Impact factor: 3.411

Review 8.  Application of Herbal Traditional Chinese Medicine in the Treatment of Acute Kidney Injury.

Authors:  Hai-Di Li; Xiao-Ming Meng; Cheng Huang; Lei Zhang; Xiong-Wen Lv; Jun Li
Journal:  Front Pharmacol       Date:  2019-04-18       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.